European Business Summits
info@ebsummit.eu – 0032 (0) 2 645 34 80
TRANSPARENCY REGISTER 268958411031-65
PRIVACY-POLICY | GENERAL TERMS OF SALES
2023 Programme
09:30 – 09:35
WELCOMING WORDS
Arnaud Thysen
Director General, European Business Summits
09:35 – 09:45
opening conversation: "fostering competition in Europe: made in the EU"
Didier Reynders
Commissioner for Justice
Commissioner for Justice
Andy Bounds,
Financial Times Correspondent
Financial Times Correspondent
09:45 – 10:00
Exclusive Interview
Lars Fruergaard Jørgensen,
CEO of Novo Nordisk, President of EFPIA
CEO of Novo Nordisk, President of EFPIA
Andy Bounds,
Financial Times Correspondent
Financial Times Correspondent
10:00 – 11:00
Building a solid infrastructure for the european digital health
Tomislav Sokol
MEP Rapporteur of EHDS
Maya Matthews
Deputy Director for Digital, EU4Health and Health Systems Modernisation at DG SANTE
Deputy Director for Digital, EU4Health and Health Systems Modernisation at DG SANTE
Enrique Terol
Health Counsellor, Spanish Representation to the EU
Health Counsellor, Spanish Representation to the EU
Dipak Kalra
President of the European Institute for Innovation through Health Data
President of the European Institute for Innovation through Health Data
José Peres
Senior Coordinator of the National Associations Council at EuropaBio
Senior Coordinator of the National Associations Council at EuropaBio
Menno Kok
Managing Director at EIT Health
Managing Director at EIT Health
The benefits of the EHDS are unrivalled and progress is being made towards its implementation. However, ensuring that its necessary components are in place will also be crucial. The question now centres around bolstering sufficient infrastructure, in tandem with both the public and private sectors, to ensure the highest levels of access, privacy and operability. Going a step further, this year EHS will be exploring how Artificial Intelligence (AI) can accelerate patient centricity in Europe.
11:00 – 11:15
Coffee break
11:15 – 11:30
Exclusive Interview on the Impact of Demographic Challenges in Healthcare
Colin Scicluna
Head of Cabinet of VP Suiča, European Commission
Giedre Peseckyte
Reporter, Euractiv
11:30 – 11:40
Keynote Address with Dr. Gaudenz Silberschmidt on Enhanced Partnerships for Global Health
Dr. Gaudenz Silberschmidt
Director for Health & Multilateral Partnerships WHO
Director for Health & Multilateral Partnerships WHO
11:00 – 11:15
Interview with Dr. Gaudenz Silberschmidt
Dr. Gaudenz Silberschmidt
Director for Health & Multilateral Partnerships, WHO
11:40 – 12:40
Strengthening public, private, academia, and tech partnerships to advance r&d for unmet needs
Emer Cooke
Executive Director, European Medicines Agency
Executive Director, European Medicines Agency
Irene Norstedt
Director, People Directorate, DG Research and Innovation
Director, People Directorate, DG Research and Innovation
Yann Le Cam
CEO, Eurordis
CEO, Eurordis
Adam Hacker
Director and Global Head Regulatory Affairs, CEPI
Director and Global Head Regulatory Affairs, CEPI
Charlotte Marchandise
Executive Director at the European Public Health Association (EUPHA)
Executive Director at the European Public Health Association (EUPHA)
Tamsin Rose
EU Health Reporter
For R&D to flourish and engender scientific breakthroughs, a conducive environment is needed. Some countries are beginning to create ecosystems for healthcare innovation, creating essential links between the scientific community, big tech, governments, and the public-private sectors. This will allow them to develop and operationalise new treatments in record time. How can the EU keep up with other regions and what steps are needed for a coordinated response?
12:40 – 13:40
Ensuring sustainable healthcare systems through the "One Health" approach
Laurent Muschel
Acting Director-General, HERA
Acting Director-General, HERA
Carlos Montañés
Executive Vice President, HIPRA
Executive Vice President, HIPRA
Andrea Corazza
Senior Director Policy & Government Affairs Europe, Novavax
Senior Director Policy & Government Affairs Europe, Novavax
Josep Figueras
Director & Cofounder, European Observatory on Health Systems and Policies
Sara Cerdas
Member of the European Parliament
Sarah-Taïssir Bencharif
EU Health Reporter
With a global population that is both growing and ageing, health systems will come under increased pressure. By considering a wider set of contributory factors for healthcare such as healthy nutrition, sustainable food, environmental, agricultural, fisheries and climate policies, we can foster resilience. The COVID-19 pandemic, other disease outbreaks and their societal and economic costs highlight the urgency of applying a One Health approach across all sectors.
13:40 – 14:40
Networking Lunch
14:40 – 15:55
A pharma strategy to foster europe's competitiveness on the global scale?
Pernille Weiss
MEP Rapporteur Pharma Directive
Anca Toma
Executive Director of the European Patients’ Forum
Executive Director of the European Patients’ Forum
Massimo Giorgio Visentin
Eastern Europe Cluster President, Pfizer
Francesca Colombo
Head of Health Division, OECD
Head of Health Division, OECD
Nathalie Moll
Director General, EFPIA
Director General, EFPIA
Mariam Zaidi
International News Presenter
International News Presenter
Europe has all the ingredients to drive innovation. It is very attractive for biopharmaceuticals, and has a highly skilled workforce, as well as promising drugs and treatments, especially in the field of rare diseases. However, the pandemic has highlighted the vulnerability of our supply chains and the need to make them more resilient. Among other concerns, there is a need to reform the healthcare sector to optimise budgets and sustainability. We need real data to highlight drug efficacy and increase population and market access. Ensuring that we have the right environment for innovation, supported by strong industrial policy, is critical to continue to foster investment in Europe.
15:55 – 16:00
Strategic Competitiveness of Europe's Pharmaceutical Industry: A Member States' Perspective
Martin Kocher
Minister for Labour and Economy of Austria
Mariam Zaidi
International News Presenter
International News Presenter
16:00 – 16:10
Coffee Break
16:10 – 17:25
Revitalising Europe's Pharmaceutical Legislation: Prioritising Patient Access and Innovation
Jeffrey Francer
VP Global Regulatory Affairs, Eli Lilly
VP Global Regulatory Affairs, Eli Lilly
Prof. Claire Paquet
Neurologist, Assistance Publique – Hôpitaux de Paris
Haseeb Ahmad
President, Europe at Novartis
Dolors Montserrat
Member of the European Parliament
Elizabeth Kuiper
Associate Director, European Policy Centre
Associate Director, European Policy Centre
Mariam Zaidi
International News Presenter
At the core of Europe’s pharmaceutical legislative reform lies a steadfast commitment to enhancing and expediting patient access to vital healthcare solutions. This unwavering dedication hinges on the level of investment in innovation across the region, encompassing various aspects such as the management of clinical trials and primary/raw data, addressing unmet medical needs, optimizing manufacturing processes for greater efficiency, and establishing a globally competitive regulatory framework coupled with prudent monitoring of supply chains.
17:30 – 17:35
Closing remarks
Giorgios Rossides,
Head of Cabinet Commissioner Kyriakides
Head of Cabinet Commissioner Kyriakides
17:25 – 17:35
Keynote address
Giorgos Rossides
Head of Cabinet Commissioner Kyriakides
17:35 – 17:40
Closing remarks
Arnaud Thysen
Director General, European Business Summits
